Pathogenesis of non-alcoholic fatty liver disease.

Joanna Dowman; Jeremy Tomlinson; Philip Newsome

doi:10.1093/qjmed/hcp158

Pathogenesis of non-alcoholic fatty liver disease.

Joanna Dowman, Jeremy Tomlinson, Philip Newsome

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

415 Citations (Scopus)

272 Downloads (Pure)

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. The prevalence of NAFLD has risen rapidly in parallel with the dramatic rise in obesity and diabetes, and is rapidly becoming the most common cause of liver disease in Western countries. Indeed, NAFLD is now recognized to be the aetiology in many cases previously labelled as cryptogenic cirrhosis.

Original language	English
Pages (from-to)	71-83
Journal	QJM
Volume	103
Issue number	2
Early online date	13 Nov 2009
DOIs	https://doi.org/10.1093/qjmed/hcp158
Publication status	Published - 1 Feb 2010

Bibliographical note

null

Readers are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the journal and Oxford University Press are attributed as the original place of publication with the correct citation details given.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/qjmed/hcp158Licence: Creative Commons: Attribution (CC BY)

Dowman.pdf

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810391/

Cite this

@article{115545f34134440a8efb65c276d1fb9e,

title = "Pathogenesis of non-alcoholic fatty liver disease.",

abstract = "Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. The prevalence of NAFLD has risen rapidly in parallel with the dramatic rise in obesity and diabetes, and is rapidly becoming the most common cause of liver disease in Western countries. Indeed, NAFLD is now recognized to be the aetiology in many cases previously labelled as cryptogenic cirrhosis.",

author = "Joanna Dowman and Jeremy Tomlinson and Philip Newsome",

note = "null Readers are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the journal and Oxford University Press are attributed as the original place of publication with the correct citation details given.",

year = "2010",

month = feb,

day = "1",

doi = "10.1093/qjmed/hcp158",

language = "English",

volume = "103",

pages = "71--83",

journal = "QJM",

issn = "1460-2393",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Pathogenesis of non-alcoholic fatty liver disease.

AU - Dowman, Joanna

AU - Tomlinson, Jeremy

AU - Newsome, Philip

N1 - null Readers are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the journal and Oxford University Press are attributed as the original place of publication with the correct citation details given.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. The prevalence of NAFLD has risen rapidly in parallel with the dramatic rise in obesity and diabetes, and is rapidly becoming the most common cause of liver disease in Western countries. Indeed, NAFLD is now recognized to be the aetiology in many cases previously labelled as cryptogenic cirrhosis.

AB - Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. The prevalence of NAFLD has risen rapidly in parallel with the dramatic rise in obesity and diabetes, and is rapidly becoming the most common cause of liver disease in Western countries. Indeed, NAFLD is now recognized to be the aetiology in many cases previously labelled as cryptogenic cirrhosis.

U2 - 10.1093/qjmed/hcp158

DO - 10.1093/qjmed/hcp158

M3 - Article

C2 - 19914930

SN - 1460-2393

VL - 103

SP - 71

EP - 83

JO - QJM

JF - QJM

IS - 2

ER -

Pathogenesis of non-alcoholic fatty liver disease.

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Cite this